Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Dose Study to Evaluate the Relative Bioavailability, Safety, and Tolerability of SUBLOCADE at Alternative Injection Locations in Adults

NCT05704543 is registered in ClinicalTrials.gov with Indivior Inc. as lead sponsor.

NCT NCT05704543
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05704543 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Dose Study to Evaluate the Relative Bioavailability, Safety, and Tolerability of SUBLOCADE at Alternative Injection Locations in Adults
Lead sponsor
Indivior Inc.
Phase
Phase 4
Overall status
Completed
Start date
March 1, 2023
Completion date
November 1, 2023
Enrollment
132 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

opioid use disorder